J. Thistlethwaite to T-Lymphocytes
This is a "connection" page, showing publications J. Thistlethwaite has written about T-Lymphocytes.
Connection Strength
0.415
-
Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 1994 Sep 15; 153(6):2738-49.
Score: 0.079
-
The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation. Transplant Proc. 1990 Aug; 22(4):1897-8.
Score: 0.060
-
T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 1):722-4.
Score: 0.047
-
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation. 1984 Dec; 38(6):695-701.
Score: 0.040
-
Immunologic characterization of MHC recombinant swine. Production of SLA class specific antisera and detection of Ia antigens on both B and non-B PBL. Transplantation. 1983 Apr; 35(4):394-400.
Score: 0.036
-
Transplantation and the CD28/CTLA4/B7 pathway. Transplant Proc. 2001 Feb-Mar; 33(1-2):209-11.
Score: 0.031
-
Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction. Transplant Proc. 1995 Feb; 27(1):395-7.
Score: 0.020
-
T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies. Transplant Proc. 1991 Feb; 23(1 Pt 1):81-2.
Score: 0.015
-
T lymphocyte activation following OKT3 treatment. Curr Surg. 1990 Nov-Dec; 47(6):458-9.
Score: 0.015
-
Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation. 1990 Oct; 50(4):608-12.
Score: 0.015
-
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb; 19(1 Pt 3):1901-4.
Score: 0.012
-
OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
Score: 0.012
-
Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol. 2000 Nov 15; 165(10):5580-7.
Score: 0.008
-
Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation. 1994 Sep 27; 58(6):681-9.
Score: 0.005
-
Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules. Transplant Proc. 1993 Feb; 25(1 Pt 1):546-7.
Score: 0.004
-
Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J Immunol. 1992 May 01; 148(9):2756-63.
Score: 0.004
-
Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies. Transplantation. 1991 Aug; 52(2):361-8.
Score: 0.004
-
OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release. Transplantation. 1991 Aug; 52(2):354-60.
Score: 0.004
-
Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors. Transplant Proc. 1987 Feb; 19(1 Pt 3):1915-6.
Score: 0.003